高原红细胞增多症诊断与治疗中国专家共识(2025)
高原红细胞增多症指长期暴露于海拔2500米以上低氧环境引发的继发性红细胞过度增多症,以血红蛋白显著升高(男性≥210 g/L,女性≥190 g/L)为主要特征。中华医学会血液学分会红细胞疾病学组和中国医院协会血液学机构分会结合最新循证证据及高原医学实践经验制定本共识,明确分层诊疗策略:轻度采取低流量氧疗,中度采取药物和氧疗并重的综合治疗,重度推荐以红细胞单采术为主,辅以药物和氧疗。
要点
- HAPC诊断阈值:男性血红蛋白≥210 g/L,女性≥190 g/L
- 轻度采取低流量氧疗,中度采取药物和氧疗并重的综合治疗
- 重度推荐以红细胞单采术为主,辅以药物和氧疗
核心结论
- 本共识明确HAPC分层诊疗策略,以指导我国HAPC临床诊治。
- 轻度采取低流量氧疗,中度采取药物和氧疗并重的综合治疗,重度推荐以红细胞单采术为主,辅以药物和氧疗。
研究设计与样本
- 由中华医学会血液学分会红细胞疾病学组和中国医院协会血液学机构分会在广泛征求有关专家意见的基础上,结合最新循证证据及高原医学实践经验制定本共识。
主要发现
- HAPC指长期暴露于海拔2500米以上低氧环境引发的继发性红细胞过度增多症。
- HAPC以血红蛋白显著升高(男性≥210 g/L,女性≥190 g/L)为主要特征。
- HAPC临床表现为头痛、乏力、睡眠障碍等,易并发血栓及器官损伤。
关键数值与推荐
- HAPC诊断阈值:男性血红蛋白≥210 g/L,女性≥190 g/L。
- 轻度:低流量氧疗。
- 中度:药物和氧疗并重的综合治疗。
- 重度:推荐以红细胞单采术为主,辅以药物和氧疗。
临床怎么用
- 按分层诊疗策略管理HAPC:轻度低流量氧疗,中度药物和氧疗并重,重度以红细胞单采术为主并辅以药物和氧疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
High-altitude polycythemia (HAPC) is defined as a secondary excessive erythrocytosis caused by prolonged exposure to hypoxic environments at altitudes above 2,500 meters, characterized primarily by significantly elevated hemoglobin levels (≥210 g/L in males and ≥190 g/L in females). Clinically, HAPC manifests as headache, fatigue, sleep disturbances, and is prone to complications such as thrombosis and organ damages. China encompasses extensive high-altitude regions of critical strategic significance, with a growing population of residents and travelers relocating or temporarily staying in these areas. However, there has been a lack of systematic and standardized clinical guidelines for the diagnosis and management of high-altitude-related diseases. To standardize the diagnosis and treatment of HAPC in China, the Red Blood Cell Disease Group, Chinese Society of Hematology, Chinese Medical Association and Chinese Hospital Association Hematology Branch formulated this consensus based on extensive expert consultation, integrating the latest evidence-based findings and practical experience in high-altitude medicine. The consensus defines a stratified diagnostic and therapeutic strategy to guide the clinical management of HAPC: mild cases are managed with low-flow oxygen therapy; moderate cases require combined pharmacological and oxygen therapy; and severe cases are recommended for erythrocytapheresis as the primary intervention, supplemented by pharmacotherapy and oxygen support. 高原红细胞增多症(HAPC)指长期暴露于海拔2 500 m以上低氧环境引发的继发性红细胞过度增多症,以血红蛋白显著升高(男性≥210 g/L,女性≥190 g/L)为主要特征。HAPC临床表现为头痛、乏力、睡眠障碍等,易并发血栓及器官损伤。我国拥有广阔的高原面积,战略位置十分重要,移居和旅居高原人员日益增多。但既往缺乏这类疾病系统规范的诊疗指导,为进一步规范我国HAPC诊疗,中华医学会血液学分会红细胞疾病学组和中国医院协会血液学机构分会在广泛征求有关专家意见的基础上,结合最新循证证据及高原医学实践经验制定了本共识,明确分层诊疗策略有助于指导HAPC诊治:轻度采取低流量氧疗,中度采取药物和氧疗并重的综合治疗,重度推荐以红细胞单采术为主,辅以药物和氧疗。.
引用
- [Chinese expert consensus on the diagnosis and treatment of high-altitude polycythemia(2025)]. Zhonghua Xue Ye Xue Za Zhi. 2025. PMID: 40598836. doi:10.3760/cma.j.cn121090-20250326-00149
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。